Last quarter (Q4 2023), KP Tissue's total revenue was C$―, a decrease of ― from the same quarter last year. In Q4, KP Tissue's net income was C$1.96M. See KP Tissue’s key income statements, including revenue, expenses, profit, and income.

Income Statement	TTM	Dec 23	Dec 22	Dec 21	Dec 20	Dec 19
Total Revenue	-	-	-	C$ 1.12M	C$ 0.00	C$ 0.00
Cost of Revenue	-	-	-	-	-	-
Gross Profit	-	-	-	C$ 1.12M	-	-
Operating Expense	C$ 903.00K	C$ 1.17M	C$ 5.21M	-	-	-
Operating Income	C$ -903.00K	C$ -1.17M	C$ -5.21M	C$ 1.12M	C$ 0.00	C$ 0.00
Net Non Operating Interest Income Expense	-	-	-	-	-	-
Other Income Expense	C$ -73.00K	C$ -335.00K	C$ 7.33M	-	-	-
Pretax Income	C$ -830.00K	C$ -830.00K	C$ -12.55M	C$ 1.12M	C$ -794.00K	C$ -4.80M
Tax Provision	C$ 4.11M	C$ 4.11M	C$ -2.30M	C$ -118.00K	C$ 1.16M	C$ 1.73M
Earnings From Equity Interest Net Of Tax	C$ -697.00K	C$ -697.00K	C$ -8.09M	-	-	-
Net Income Common Stockholders	C$ -4.94M	C$ -4.94M	C$ -10.25M	C$ 1.24M	C$ -1.95M	C$ -6.53M
Basic EPS	C$ -0.49	C$ -0.50	C$ -1.03	C$ 0.13	C$ -0.20	C$ -0.68
Diluted EPS	C$ 0.58	C$ -0.50	C$ -1.03	C$ 0.13	C$ -0.20	C$ -0.68
Basic Average Shares	C$ 39.82M	C$ 9.96M	C$ 9.94M	C$ 9.84M	C$ 9.70M	C$ 9.54M
Diluted Average Shares	C$ 39.82M	C$ 9.96M	C$ 9.94M	C$ 9.84M	C$ 9.70M	C$ 9.54M
Dividend Per Share	C$ 0.36	C$ 0.18	C$ 0.18	C$ 0.18	C$ 0.72	C$ 0.72
Total Operating Income As Reported	-	-	-	-	-	-
Reported Normalized Basic E P S	-	-	-	-	-	-
Reported Normalized Diluted E P S	-	-	-	-	-	-
Rent Expense Supplemental	-	-	-	-	-	-
Total Expenses	C$ 624.00K	-	C$ 5.21M	-	-	-
Net Income From Continuing And Discontinued Operation	C$ -4.94M	C$ -4.94M	C$ -10.25M	C$ 1.24M	C$ -1.95M	C$ -6.53M
Normalized Income	C$ -610.05K	C$ -610.05K	C$ -14.85M	C$ 1.00M	C$ -2.42M	C$ -6.95M
Interest Expense	-	-	-	-	-	-
EBIT	C$ -830.00K	C$ -830.00K	C$ -12.55M	C$ 1.12M	C$ 0.00	C$ 0.00
EBITDA	C$ 335.00K	C$ 335.00K	C$ -7.33M	C$ 1.12M	C$ 0.00	C$ 0.00

Currency in CAD

KP Tissue Earnings and Revenue History

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing